WCM Investment Management
MDGL icon

WCM Investment Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

WCM Investment Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.9M Buy
23,560
+6,306
+37% +$3.01M 0.03% 133
2025
Q4 		$10.1M Sell
17,254
-1,037
-6% -$530K 0.02% 150
2025
Q3 		$8.1M Buy
+18,291
New +$6.82M 0.02% 151

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WCM Investment Management's MDGL Position: Q1 2026 in Review

WCM Investment Management increased its Madrigal Pharmaceuticals (MDGL) stake by 37% in Q1 2026, buying an estimated $3.01M and bringing the position to 23,560 shares worth $11.9M. The position accounts for 0.03% of the portfolio, ranked #133.

WCM Investment Management first reported a position in MDGL in Q3 2025 and has held it in 3 quarters since. 378 funds tracked by Wall St. Rank hold MDGL as of Q1 2026.

  • WCM Investment Management held 23,560 shares of Madrigal Pharmaceuticals worth $11.9M as of Q1 2026.
  • WCM Investment Management bought 6,306 Madrigal Pharmaceuticals shares in Q1 2026, an estimated $3.01M.
  • Madrigal Pharmaceuticals made up 0.03% of WCM Investment Management's portfolio in Q1 2026, its #133 holding.
  • WCM Investment Management first reported a position in Madrigal Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 378 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2026.

Based on WCM Investment Management's 13F filing for Q1 2026, filed 7 May 2026.